Retatrutide is a synthetic peptide, which research indicates functions as a triple agonist for type 2 diabetes and weight loss. Peptides, small chains of amino acids, have been hypothesized to ...

Retatrutide — an experimental drug nicknamed “triple G” — could be your best shot at a slimmer waistline when it becomes available to the public, a Monday study found. Obese adults who ...

its tolerability could offer an edge over retatrutide, which is expected to have slightly more side effects than Zepbound. Last month, Structure Therapeutics selected ACCG-2671 as its lead oral ...

The authors found that individuals on retatrutide (12 mg once-weekly injection) lost 22% of body weight from baseline after 48 weeks. Tirzepatide (15 mg once-weekly injection) recipients lost ...